Form D · Pharmaceuticals
TITAN PARTNERS, LLC
Dallas, TX · CIK 0001595404
Offering snapshot reported Mar 11, 2015 · SEC filing
- Reported sold
- $248K Offering amount: $353K
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Feb 25, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2015 | Initial | $247,607 | No comparison | 19 | SEC filing |
| Dec 30, 2013 | Initial | $250,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235676
Source: Form D, filed Mar 11, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Kamran Nezami, | Executive |
| Kamran Nezami | Executive |
| Llc Titan Partners Management, | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2100 Mckinney Avenue, Suite 1780
Dallas, TX, 75201
Dallas, TX, 75201